Andrés López Roldán - Clinical Trial Investigator | Syfrah

Trials Sponsors Conditions Drugs Pricing

Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

PROCEDURE(3)

MIXED(1)

DRUG(1)

Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML

andres-lopez-roldan

Enamel Matrix Proteins (Active comparator group)

andres-lopez-roldan

Flapless instrumentation of the defect following MINST in conjuction with NaOCl and hyaluronic acid application

university-of-valencia

Flapless instrumentation of the defect following MINST, root conditioning with EDTA and EMD application

university-of-valencia

Flapless instrumentation of the defect and product application simulation

university-of-valencia

5 unique interventions3 categories

Analytics

Trial Phases

Phase 41

Trial Status

Completed1

Recruiting1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT07339605Not ApplicableRecruiting

Flapless Periodontal Regeneration Using Hyaluronic Acid Versus Enamel Matrix Derivative

Alveolar Bone Loss* / TherapyDental Enamel Proteins* / Therapeutic UseFlapless+4 more

StudydirectorStart date: 2024-10-26

NCT04274244Phase 4Completed

Comparison of Clinical and Radiographic Parameters in the Application of Cross-linked Hyaluronic Acid 1.8% and Enamel Matrix Derivative in Periodontal Regeneration.

Chronic PeriodontitisPeriodontal Bone Loss

StudydirectorStart date: 2020-03-01

Research Network

Collaboration Network

3 collaborators·2 connections

Network Legend

KOL

Current Investigator

CO

High-influence Collaborator

CO

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Alveolar Bone Loss* / Therapy1 Chronic Periodontitis1 Dental Enamel Proteins* / Therapeutic Use1 Flapless1 Guided Tissue Regeneration, Periodontal / Methods1 Humans1 Hyaluronic Acid* / Therapeutic Use1 Intrabony Defect1

Affiliations

University of Valencia

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

José Manuel Almerich Silla

University of Valencia

Shared therapeutic areas:

Alveolar Bone Loss* / TherapyDental Enamel Proteins* / Therapeutic UseFlapless+4 more

Worked with same sponsors:

University of Valencia

Collaborated on 1 trial

Similarity Score74%

Manuel Rodríguez Aranda

University of Valencia

Shared therapeutic areas:

Chronic PeriodontitisAlveolar Bone Loss

Worked with same sponsors:

Andres Lopez RoldanRegedent AG, Zürich

Collaborated on 1 trial

Similarity Score24%

Saverio Capodiferro, Prof

University of Bari Aldo Moro

Shared therapeutic areas:

Alveolar Bone Loss

Similarity Score3%

João Caramês, Phd

Implantology Institute

Shared therapeutic areas:

Alveolar Bone Loss

Similarity Score3%

zeynep taştan eroğlu

Necmettin Erbakan University

Shared therapeutic areas:

Alveolar Bone Loss

Similarity Score3%

Umut Ballı, DDS

Bülent Ecevit University Faculty of Dentistry

Shared therapeutic areas:

Chronic Periodontitis

Similarity Score3%

Magda Feres, Professor

Guarulhos University

Shared therapeutic areas:

Chronic Periodontitis

Similarity Score3%

Novartis vaccines and Diagnostics

Novartis Vaccines

Shared therapeutic areas:

Similarity Score3%

Walid AH Elamrousy, PhD

Faculty of Oral and Dental Medicine, Kafrelsheikh University

Shared therapeutic areas:

Alveolar Bone Loss

Similarity Score3%

Magued H Fahmy, PhD

Faculty of Dentistry, Alexandria University, Egypt

Shared therapeutic areas:

Alveolar Bone Loss

Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT07339605Not ApplicableStudyDirector

Flapless Periodontal Regeneration Using Hyaluronic Acid Versus Enamel Matrix Derivative

Alveolar Bone Loss* / TherapyDental Enamel Proteins* / Therapeutic UseFlapless+4 more

Recruiting

NCT04274244Phase 4StudyDirector

Comparison of Clinical and Radiographic Parameters in the Application of Cross-linked Hyaluronic Acid 1.8% and Enamel Matrix Derivative in Periodontal Regeneration.

Chronic PeriodontitisPeriodontal Bone Loss

Completed

All 2 trials loaded